Objective We examined associations between ulcer bioburden and ulcer outcomes in neuropathic diabetic foot ulcers (DFUs) that lacked clinical signs of infection. Research Design and Methods Three ...
Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...
Mölnlycke Health Care has announced an $8 million investment in Siren, which makes the Siren sock, a temperature sensing textile technology, to help reduce the risk of diabetic ...
ABSTRACT: The science of artificial intelligence is rapidly expanding, and its application to the global diabetes pandemic could revolutionize how this chronic disease is diagnosed and managed. AI has ...
Diabetic neuropathy is a polyneuropathy because ... and autonomic − all of which have bearing on the development of foot problems in this patient population. Motor neuropathy causes atrophy ...